Blood Bank & Transfusion Records
Buy and sell blood bank & transfusion records data. Type, screen, crossmatch, transfusion reactions — blood management AI needs real transfusion outcome data.
No listings currently in the marketplace for Blood Bank & Transfusion Records.
Find Me This Data →Overview
What Is Blood Bank & Transfusion Records Data?
Blood bank and transfusion records data encompasses comprehensive documentation of blood type screening, crossmatching, transfusion reactions, and blood component management. This dataset is critical for healthcare systems, blood management software platforms, and AI-driven transfusion services that require real-world outcome data to improve safety and efficiency. The market spans hospital laboratories, independent blood banks, and clinical settings where accurate transfusion data directly impacts patient safety and blood inventory optimization.
Market Data
$2.20B (2022) → $3.58B (2029)
U.S. Blood Transfusion Diagnostics Market Growth
Source: Fortune Business Insights
$1.34B (2026) → $2.05B (2031)
Blood Management Software Market Size
Source: Mordor Intelligence
$27.07B (2026) → $43.76B (2033)
Blood Banking Devices Market Projection
Source: Coherent Market Insights
8.84% (2026–2031)
Blood Management Software CAGR
Source: Mordor Intelligence
Who Uses This Data
What AI models do with it.do with it.
Blood Management Software Platforms
Donation management, transfusion service modules, and electronic lookback systems use transfusion outcome records to optimize inventory, track donor history, and automate safety protocols.
Hospital Laboratories & Blood Banks
Hospital-based and independent blood banks rely on screening, typing, and transfusion reaction data to standardize blood component processing and minimize adverse events.
AI & Diagnostic Developers
AI systems for blood management require real transfusion outcome data to train algorithms that predict compatibility, detect transfusion reactions, and improve donor-recipient matching.
Automated Blood Processing Equipment Makers
Manufacturers of automated blood processing and testing devices integrate transfusion records to validate equipment performance and demonstrate safety improvements.
Pricing depends on the proposed terms
We do not have a verified, comparable price for your dataset. Consider the permitted uses, license term, exclusivity, provenance, coverage and quality. A seller asking price is a proposal, not an appraisal or guaranteed sale. Compare prices only when the source, date, currency, unit and license scope are known.
What Buyers Expect
What makes it valuable.valuable.
HIPAA Compliance & De-identification
All patient identifiers must be removed; records must comply with HIPAA Safe Harbor or Expert Determination standards.
Complete Clinical Context
Buyers require transfusion indication, blood product type, transfusion date/time, reaction onset timing, symptoms, and clinical interventions.
Standardized Data Fields
Records should use ISBT (International Society of Blood Transfusion) terminology for blood group, component coding, and reaction classification.
Longitudinal Donor & Recipient Linkage
Outcome data must maintain consistent pseudonymized identifiers to track repeat transfusions, donor patterns, and long-term transfusion history.
Quality & Assurance Documentation
Lab certifications (CAP, CLIA), test methodology validation, reagent lot tracking, and equipment calibration records enhance dataset credibility.
Potential applications and organizations
Who's buying.buying.
Blood management software, automated processing devices, and transfusion service platforms for hospital networks.
EHR integration and AI-driven conversational interfaces that surface transfusion data for clinical decision support.
Blood management software industry leader building cloud-native platforms with embedded analytics and consumption-based pricing.
Automated blood processing equipment (20–25% market share) integrating transfusion outcome validation.
Blood component manufacturing and transfusion service provider utilizing outcome data for product quality assurance.
FAQ
Common questions.questions.
What is driving growth in blood transfusion diagnostics data demand?
Rising volume of voluntary blood donations, prevalence of blood-related disorders, increasing hospital transfusion volumes, and adoption of automation in blood processing all drive demand for comprehensive transfusion outcome datasets. AI and machine learning applications in blood management software also require real-world transfusion data for algorithm training.
Which data points are most valuable in transfusion records?
Transfusion reaction reports (type, timing, severity), blood type screening results (ABO, Rh, antibody panel), crossmatch outcomes (immediate spin, indirect antiglobulin test results), donor-recipient matching records, and clinical indications for transfusion. Longitudinal linkage across multiple transfusions per patient adds significant value.
How should transfusion records be de-identified?
Records must remove all direct identifiers (name, medical record number, date of birth). Consistent pseudonymized identifiers can be retained to link repeat transfusions and donor patterns, provided they cannot be re-identified. All dates should be shifted or aggregated. Comply with HIPAA Safe Harbor standards or obtain Expert Determination attestation.
Who are the primary institutional buyers of this data?
Blood management software vendors (Veradigm, WellSky, Haemonetics, Oracle), automated blood processing equipment manufacturers (Terumo, Fresenius Kabi, Abbott), hospital networks, regional blood centers, and AI diagnostic developers building transfusion prediction and safety monitoring systems.
Sell yourblood bank & transfusion recordsdata.
Describe your blood bank & transfusion records and the uses you are authorized to offer. Price, legal suitability, and buyer interest require separate evaluation. No match or sale is guaranteed.
Prepare a Listing